I am doing mammaprint on all patients with tumor 1cm or greater.
Mammaprint is a 70 gene assay that can be used determine if a breast cancer is high risk or low risk for recurrence. Additionally it allows for tumor subtyping so that we can know if the tumor is luminal, basal or her2neu over-expressing. This can be very helpful for helping patients make decisions about the potential benefit of chemotherapy as well as helping to decide which medications are most effective. This assay can only be done on fresh tumor tissue either obtained at the time of core biopsy or during surgery.
I am doing mammaprint on all patients with tumor 1cm or greater.
Mammaprint is a 70 gene assay that can be used determine if a breast cancer is high risk or low risk for recurrence. Additionally it allows for tumor subtyping so that we can know if the tumor is luminal, basal or her2neu over-expressing. This can be very helpful for helping patients make decisions about the potential benefit of chemotherapy as well as helping to decide which medications are most effective. This assay can only be done on fresh tumor tissue either obtained at the time of core biopsy or during surgery.
Call SHARE at: 866-891-2392
to speak directly to a trained breast cancer survivor for support and guidance.
3 Quick Ways You Can Help
1) Spread the word! Tell people you think might want some support. Tell medical professionals, health providers, and organizations.
2) Like us on Facebook and follow us on Twitter! 3) Volunteer - email us at volunteer@talkabouthealth.com for more information.
Mammaprint is a 70 gene assay that can be used determine if a breast cancer is high risk or low risk for recurrence. Additionally it allows for tumor subtyping so that we can know if the tumor is luminal, basal or her2neu over-expressing. This can be very helpful for helping patients make decisions about the potential benefit of chemotherapy as well as helping to decide which medications are most effective. This assay can only be done on fresh tumor tissue either obtained at the time of core biopsy or during surgery. I am doing mammaprint on all patients with tumor 1cm or greater.
Mammaprint is a 70 gene assay that can be used determine if a breast cancer is high risk or low risk for recurrence. Additionally it allows for tumor subtyping so that we can know if the tumor is luminal, basal or her2neu over-expressing. This can be very helpful for helping patients make decisions about the potential benefit of chemotherapy as well as helping to decide which medications are most effective. This assay can only be done on fresh tumor tissue either obtained at the time of core biopsy or during surgery.
Note: Usernames have been made anonymous and profile images are not shown to protect the privacy of our members.